Tramadol in traumatic brain injury: Should we continue to use it?

Saeed Mahmood, Hassan Al-Thani, Ayman El-Menyar, Mushrek Alani, Ammar Al-Hassani, Saji Mathrdikkal, Ruben Peralta, Rifat - Latifi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background and Aims: Tramadol is commonly used to treat moderate to moderately-severe pain in adults. We aimed to analyze the clinical relevance of tramadol use during weaning and extubation in patients with traumatic brain injury (TBI). Material and Methods: A retrospective observational study was conducted and included all the intubated TBI patients at the level I trauma center between 2011 and 2012. Data included patient's demographics, mechanism of injury (MOI), Glasgow Coma Scale (GCS), injury severity score, length of Intensive Care Unit (ICU) stay length of stay (LOS), agitation scale, analgesics, failure of extubation and tracheostomy. Patients were divided into two groups based on whether they received tramadol (Group 1) or not (Group 2) during ventilatory weaning. Chi-square and Student's t-tests were used for categorical and continuous variables; respectively. Logistic regression analysis was performed for predictors of agitation in ICU. Results: The study included 393 TBI patients; the majority (96%) was males with a mean age of 33.6 ± 14 years. The most common MOI were motor vehicle crash (39%), fall (29%) and pedestrian (17%). The associated injuries were mainly chest (35%) and abdominal (16%) trauma. Tramadol was administered in 51.4% of TBI patients. Tracheostomy was performed in 12.4% cases. Agitation was observed in 34.2% cases. Group 1 patients had significantly lower age (31.6 ± 12.4 vs. 35.7 ± 15.6; P = 0.005) and head AIS (3.5 ± 0.8 vs. 3.9 ± 0.9; P = 0.001) compared to Group 2. The incidence of agitation, ICU and hospital LOS were higher in Group 1. Failure of extubation and tracheostomy were reported more frequently in Group 1 (P = 0.001). On multivariate analysis, tramadol use was an independent predictor for agitation (adjusted odds ratio 21; P = 0.001), followed by low GCS. Conclusion: Patients with TBI who received tramadol are more likely to develop agitation, undergo tracheostomy and to have longer hospital LOS. Therefore, an extensive risk-benefit assessment would help to attain maximum efficacy of the drug in TBI patients.

Original languageEnglish (US)
Pages (from-to)344-348
Number of pages5
JournalJournal of Anaesthesiology Clinical Pharmacology
Volume31
Issue number3
DOIs
StatePublished - Jul 1 2015

Fingerprint

Tramadol
Tracheostomy
Length of Stay
Intensive Care Units
Glasgow Coma Scale
Wounds and Injuries
Weaning
Traumatic Brain Injury
Injury Severity Score
Trauma Centers
Motor Vehicles
Observational Studies
Analgesics
Thorax
Multivariate Analysis
Retrospective Studies
Logistic Models
Odds Ratio
Head
Regression Analysis

Keywords

  • Agitation
  • brain injury
  • extubation
  • tramadol
  • trauma

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Anesthesiology and Pain Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Tramadol in traumatic brain injury : Should we continue to use it? / Mahmood, Saeed; Al-Thani, Hassan; El-Menyar, Ayman; Alani, Mushrek; Al-Hassani, Ammar; Mathrdikkal, Saji; Peralta, Ruben; Latifi, Rifat -.

In: Journal of Anaesthesiology Clinical Pharmacology, Vol. 31, No. 3, 01.07.2015, p. 344-348.

Research output: Contribution to journalArticle

Mahmood, S, Al-Thani, H, El-Menyar, A, Alani, M, Al-Hassani, A, Mathrdikkal, S, Peralta, R & Latifi, R 2015, 'Tramadol in traumatic brain injury: Should we continue to use it?', Journal of Anaesthesiology Clinical Pharmacology, vol. 31, no. 3, pp. 344-348. https://doi.org/10.4103/0970-9185.161670
Mahmood S, Al-Thani H, El-Menyar A, Alani M, Al-Hassani A, Mathrdikkal S et al. Tramadol in traumatic brain injury: Should we continue to use it? Journal of Anaesthesiology Clinical Pharmacology. 2015 Jul 1;31(3):344-348. https://doi.org/10.4103/0970-9185.161670
Mahmood, Saeed ; Al-Thani, Hassan ; El-Menyar, Ayman ; Alani, Mushrek ; Al-Hassani, Ammar ; Mathrdikkal, Saji ; Peralta, Ruben ; Latifi, Rifat -. / Tramadol in traumatic brain injury : Should we continue to use it?. In: Journal of Anaesthesiology Clinical Pharmacology. 2015 ; Vol. 31, No. 3. pp. 344-348.
@article{7fb72d8617a84ee98097765001825177,
title = "Tramadol in traumatic brain injury: Should we continue to use it?",
abstract = "Background and Aims: Tramadol is commonly used to treat moderate to moderately-severe pain in adults. We aimed to analyze the clinical relevance of tramadol use during weaning and extubation in patients with traumatic brain injury (TBI). Material and Methods: A retrospective observational study was conducted and included all the intubated TBI patients at the level I trauma center between 2011 and 2012. Data included patient's demographics, mechanism of injury (MOI), Glasgow Coma Scale (GCS), injury severity score, length of Intensive Care Unit (ICU) stay length of stay (LOS), agitation scale, analgesics, failure of extubation and tracheostomy. Patients were divided into two groups based on whether they received tramadol (Group 1) or not (Group 2) during ventilatory weaning. Chi-square and Student's t-tests were used for categorical and continuous variables; respectively. Logistic regression analysis was performed for predictors of agitation in ICU. Results: The study included 393 TBI patients; the majority (96{\%}) was males with a mean age of 33.6 ± 14 years. The most common MOI were motor vehicle crash (39{\%}), fall (29{\%}) and pedestrian (17{\%}). The associated injuries were mainly chest (35{\%}) and abdominal (16{\%}) trauma. Tramadol was administered in 51.4{\%} of TBI patients. Tracheostomy was performed in 12.4{\%} cases. Agitation was observed in 34.2{\%} cases. Group 1 patients had significantly lower age (31.6 ± 12.4 vs. 35.7 ± 15.6; P = 0.005) and head AIS (3.5 ± 0.8 vs. 3.9 ± 0.9; P = 0.001) compared to Group 2. The incidence of agitation, ICU and hospital LOS were higher in Group 1. Failure of extubation and tracheostomy were reported more frequently in Group 1 (P = 0.001). On multivariate analysis, tramadol use was an independent predictor for agitation (adjusted odds ratio 21; P = 0.001), followed by low GCS. Conclusion: Patients with TBI who received tramadol are more likely to develop agitation, undergo tracheostomy and to have longer hospital LOS. Therefore, an extensive risk-benefit assessment would help to attain maximum efficacy of the drug in TBI patients.",
keywords = "Agitation, brain injury, extubation, tramadol, trauma",
author = "Saeed Mahmood and Hassan Al-Thani and Ayman El-Menyar and Mushrek Alani and Ammar Al-Hassani and Saji Mathrdikkal and Ruben Peralta and Latifi, {Rifat -}",
year = "2015",
month = "7",
day = "1",
doi = "10.4103/0970-9185.161670",
language = "English (US)",
volume = "31",
pages = "344--348",
journal = "Journal of Anaesthesiology Clinical Pharmacology",
issn = "0970-9185",
publisher = "Journal of Anaesthesiology Clinical Pharmacology",
number = "3",

}

TY - JOUR

T1 - Tramadol in traumatic brain injury

T2 - Should we continue to use it?

AU - Mahmood, Saeed

AU - Al-Thani, Hassan

AU - El-Menyar, Ayman

AU - Alani, Mushrek

AU - Al-Hassani, Ammar

AU - Mathrdikkal, Saji

AU - Peralta, Ruben

AU - Latifi, Rifat -

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Background and Aims: Tramadol is commonly used to treat moderate to moderately-severe pain in adults. We aimed to analyze the clinical relevance of tramadol use during weaning and extubation in patients with traumatic brain injury (TBI). Material and Methods: A retrospective observational study was conducted and included all the intubated TBI patients at the level I trauma center between 2011 and 2012. Data included patient's demographics, mechanism of injury (MOI), Glasgow Coma Scale (GCS), injury severity score, length of Intensive Care Unit (ICU) stay length of stay (LOS), agitation scale, analgesics, failure of extubation and tracheostomy. Patients were divided into two groups based on whether they received tramadol (Group 1) or not (Group 2) during ventilatory weaning. Chi-square and Student's t-tests were used for categorical and continuous variables; respectively. Logistic regression analysis was performed for predictors of agitation in ICU. Results: The study included 393 TBI patients; the majority (96%) was males with a mean age of 33.6 ± 14 years. The most common MOI were motor vehicle crash (39%), fall (29%) and pedestrian (17%). The associated injuries were mainly chest (35%) and abdominal (16%) trauma. Tramadol was administered in 51.4% of TBI patients. Tracheostomy was performed in 12.4% cases. Agitation was observed in 34.2% cases. Group 1 patients had significantly lower age (31.6 ± 12.4 vs. 35.7 ± 15.6; P = 0.005) and head AIS (3.5 ± 0.8 vs. 3.9 ± 0.9; P = 0.001) compared to Group 2. The incidence of agitation, ICU and hospital LOS were higher in Group 1. Failure of extubation and tracheostomy were reported more frequently in Group 1 (P = 0.001). On multivariate analysis, tramadol use was an independent predictor for agitation (adjusted odds ratio 21; P = 0.001), followed by low GCS. Conclusion: Patients with TBI who received tramadol are more likely to develop agitation, undergo tracheostomy and to have longer hospital LOS. Therefore, an extensive risk-benefit assessment would help to attain maximum efficacy of the drug in TBI patients.

AB - Background and Aims: Tramadol is commonly used to treat moderate to moderately-severe pain in adults. We aimed to analyze the clinical relevance of tramadol use during weaning and extubation in patients with traumatic brain injury (TBI). Material and Methods: A retrospective observational study was conducted and included all the intubated TBI patients at the level I trauma center between 2011 and 2012. Data included patient's demographics, mechanism of injury (MOI), Glasgow Coma Scale (GCS), injury severity score, length of Intensive Care Unit (ICU) stay length of stay (LOS), agitation scale, analgesics, failure of extubation and tracheostomy. Patients were divided into two groups based on whether they received tramadol (Group 1) or not (Group 2) during ventilatory weaning. Chi-square and Student's t-tests were used for categorical and continuous variables; respectively. Logistic regression analysis was performed for predictors of agitation in ICU. Results: The study included 393 TBI patients; the majority (96%) was males with a mean age of 33.6 ± 14 years. The most common MOI were motor vehicle crash (39%), fall (29%) and pedestrian (17%). The associated injuries were mainly chest (35%) and abdominal (16%) trauma. Tramadol was administered in 51.4% of TBI patients. Tracheostomy was performed in 12.4% cases. Agitation was observed in 34.2% cases. Group 1 patients had significantly lower age (31.6 ± 12.4 vs. 35.7 ± 15.6; P = 0.005) and head AIS (3.5 ± 0.8 vs. 3.9 ± 0.9; P = 0.001) compared to Group 2. The incidence of agitation, ICU and hospital LOS were higher in Group 1. Failure of extubation and tracheostomy were reported more frequently in Group 1 (P = 0.001). On multivariate analysis, tramadol use was an independent predictor for agitation (adjusted odds ratio 21; P = 0.001), followed by low GCS. Conclusion: Patients with TBI who received tramadol are more likely to develop agitation, undergo tracheostomy and to have longer hospital LOS. Therefore, an extensive risk-benefit assessment would help to attain maximum efficacy of the drug in TBI patients.

KW - Agitation

KW - brain injury

KW - extubation

KW - tramadol

KW - trauma

UR - http://www.scopus.com/inward/record.url?scp=84938236845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938236845&partnerID=8YFLogxK

U2 - 10.4103/0970-9185.161670

DO - 10.4103/0970-9185.161670

M3 - Article

AN - SCOPUS:84938236845

VL - 31

SP - 344

EP - 348

JO - Journal of Anaesthesiology Clinical Pharmacology

JF - Journal of Anaesthesiology Clinical Pharmacology

SN - 0970-9185

IS - 3

ER -